(Q54641208)

English

[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014]. (English)

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

1 reference

based on heuristic

inferred from title

author name string

A Heiligenhaus

1

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

B Bertram

2

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

C Heinz

3

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

L Krause

4

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

U Pleyer

5

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

J Roider

6

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

S Sauer

7

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

S Thurau

8

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

German Ophthalmological Society

9

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

Retina Society

10

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

Professional Association of German Ophthalmologists

11

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

language of work or name

0 references

publication date

1 August 2014

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

111

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

740-748

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

8

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

https://scigraph.springernature.com/pub.10.1007/s00347-014-3130-0

0 references

Ranibizumab for refractory uveitis-related macular edema.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal adalimumab for refractory uveitis-related macular edema.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Vitrectomy in the treatment of uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Vascular endothelial growth factor inhibition in uveitis: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Outcome of intravitreal triamcinolone in uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

The use of interferon alpha in Behçet disease: review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Bevacizumab in inflammatory eye disease

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Bevacizumab vs. triamcinolone

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results.

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

1 reference

https://api.crossref.org/works/10.1007%2FS00347-014-3130-0

21 January 2018

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for treatment of uveitic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of inflammatory cystoid macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uveitic cystoid macular edema: intravitreal triamcinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone acetonide concentration after subtenon injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitrectomy in Intermediate Uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25118844

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00347-014-3130-0

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/25118844

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54641208&oldid=1424440442"